KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Emergent BioSolutions (EBS) Return on Equity (2016 - 2025)

Historic Return on Equity for Emergent BioSolutions (EBS) over the last 17 years, with Q3 2025 value amounting to 0.14%.

  • Emergent BioSolutions' Return on Equity rose 6000.0% to 0.14% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.14%, marking a year-over-year increase of 6000.0%. This contributed to the annual value of 0.34% for FY2024, which is 4100.0% up from last year.
  • Emergent BioSolutions' Return on Equity amounted to 0.14% in Q3 2025, which was up 6000.0% from 0.26% recorded in Q2 2025.
  • In the past 5 years, Emergent BioSolutions' Return on Equity ranged from a high of 0.26% in Q1 2021 and a low of 1.13% during Q4 2023
  • Over the past 5 years, Emergent BioSolutions' median Return on Equity value was 0.15% (recorded in 2022), while the average stood at 0.26%.
  • In the last 5 years, Emergent BioSolutions' Return on Equity tumbled by -9800bps in 2023 and then soared by 13700bps in 2025.
  • Quarter analysis of 5 years shows Emergent BioSolutions' Return on Equity stood at 0.14% in 2021, then plummeted by -208bps to 0.15% in 2022, then crashed by -644bps to 1.13% in 2023, then skyrocketed by 66bps to 0.38% in 2024, then skyrocketed by 135bps to 0.14% in 2025.
  • Its Return on Equity was 0.14% in Q3 2025, compared to 0.26% in Q2 2025 and 0.25% in Q1 2025.